Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome.
Weiss GJ, Tibes R, Blaydorn L, Jameson G, Downhour M, White E, Caro I, Von Hoff DD. Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome. Dermatol Reports. 2011 Oct 05; 3(3):e55.